Patent: 9,465,027
✉ Email this page to a colleague
Summary for Patent: 9,465,027
Title: | Assays for detecting neutralizing autoantibodies to biologic therapy |
Abstract: | The present invention provides assays for detecting and measuring the presence or level of neutralizing and non-neutralizing autoantibodies to biologics such as anti-TNF.alpha. drug therapeutics in a sample. The present invention is useful for monitoring the formation of neutralizing and/or non-neutralizing anti-drug antibodies over time while a subject is on biologic therapy. The present invention is also useful for predicting and/or determining the cross-reactivity of neutralizing anti-drug antibodies in a subject\'s sample with alternative biologic therapies. As such, the present invention provides information for guiding treatment decisions for those subjects receiving therapy with a biologic agent and improves the accuracy of optimizing therapy, reducing toxicity, and/or monitoring the efficacy of therapeutic treatment to biologic therapy. |
Inventor(s): | Hauenstein; Scott (San Diego, CA), Ohrmund; Linda (San Diego, CA), Singh; Sharat (Rancho Santa Fe, CA), Wang; Shui Long (San Diego, CA) |
Assignee: | Nestec S.A. (Vevey, CH) |
Application Number: | 14/144,261 |
Patent Claims: | see list of patent claims |
Details for Patent 9,465,027
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2031-07-06 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2031-07-06 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2031-07-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |